Literature DB >> 20542588

Positive T cell co-stimulation by TLR7/8 ligands is dependent on the cellular environment.

Denise Richardt-Pargmann1, Miriam Wechsler, Arthur M Krieg, Jörg Vollmer, Marion Jurk.   

Abstract

Toll-like receptors (TLRs) are mediators of innate immune responses detecting conserved pathogen-associated molecules. Whereas most TLRs are expressed on the cell surface, TLR3, 7, 8 and 9 are predominantly localized in endosomal compartments. Recent studies reported that TLRs are also expressed by T lymphocytes, resulting in direct co-stimulation of isolated CD4(+) T cells for example by Pam3CSK4 (TLR2 ligand) or flagellin (TLR5 ligand). We here describe enhanced IFN-γ production and T cell proliferation by anti-CD3 T cell receptor (TCR) or antigenic stimulation of purified human CD4(+) T cells upon co-culture with TLR7/8 specific single-stranded oligoribonucleotides or small molecule ligands. Surprisingly, TLR7/8 stimulation of CD4(+) T cells within a whole peripheral mononuclear cell (PBMC) environment did not result in enhanced T cell proliferation, but in a lack of proliferation that was cell-cell contact dependent. Immune cell depletion assays pointed towards a monocyte-mediated effect. Different TLR ligands influenced T cell proliferation differently. The effect of inhibition of T cell proliferation was most prominently seen for TLR7 ligands whereas the effects were minimal for TLR8 and TLR9 ligands indicating that the suppressive phenotype is unique only for certain TLRs. Our results strongly suggest that co-stimulation of T cell proliferation by TLR7/8 agonists is dependent on the specific cellular context.
Copyright © 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542588      PMCID: PMC2964431          DOI: 10.1016/j.imbio.2010.03.011

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  74 in total

Review 1.  Activation and inhibition of lymphocytes by costimulation.

Authors:  Kenneth A Frauwirth; Craig B Thompson
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 2.  Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity.

Authors:  Hermann Wagner
Journal:  Curr Opin Microbiol       Date:  2002-02       Impact factor: 7.934

Review 3.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

4.  Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848.

Authors:  Marion Jurk; Florian Heil; Jörg Vollmer; Christian Schetter; Arthur M Krieg; Hermann Wagner; Grayson Lipford; Stefan Bauer
Journal:  Nat Immunol       Date:  2002-06       Impact factor: 25.606

5.  Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling.

Authors:  Misako Matsumoto; Satomi Kikkawa; Masayoshi Kohase; Kensuke Miyake; Tsukasa Seya
Journal:  Biochem Biophys Res Commun       Date:  2002-05-24       Impact factor: 3.575

6.  Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.

Authors:  Hiroaki Hemmi; Tsuneyasu Kaisho; Osamu Takeuchi; Shintaro Sato; Hideki Sanjo; Katsuaki Hoshino; Takao Horiuchi; Hideyuki Tomizawa; Kiyoshi Takeda; Shizuo Akira
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

7.  PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.

Authors:  LauraL Carter; Lynette A Fouser; Jason Jussif; Lori Fitz; Bija Deng; Clive R Wood; Mary Collins; Tasuku Honjo; Gordon J Freeman; Beatriz M Carreno
Journal:  Eur J Immunol       Date:  2002-03       Impact factor: 5.532

8.  Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.

Authors:  Veit Hornung; Simon Rothenfusser; Stefanie Britsch; Anne Krug; Bernd Jahrsdörfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

Review 9.  Toll-like receptors: their role in allergy and non-allergic inflammatory disease.

Authors:  I Sabroe; L C Parker; A G Wilson; M K B Whyte; S K Dower
Journal:  Clin Exp Allergy       Date:  2002-07       Impact factor: 5.018

10.  Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments.

Authors:  Parviz Ahmad-Nejad; Hans Häcker; Mark Rutz; Stefan Bauer; Ramunas M Vabulas; Hermann Wagner
Journal:  Eur J Immunol       Date:  2002-07       Impact factor: 5.532

View more
  9 in total

1.  Prior TLR5 induction in human T cells results in a transient potentiation of subsequent TCR-induced cytokine production.

Authors:  Mikaela M Tremblay; Mahmood Y Bilal; Jon C D Houtman
Journal:  Mol Immunol       Date:  2013-10-12       Impact factor: 4.407

2.  Nucleotide-binding and oligomerization domain-like receptors and retinoic acid inducible gene-like receptors in human tonsillar T lymphocytes.

Authors:  Terese Petterson; Anne Månsson; Kristian Riesbeck; Lars O Cardell
Journal:  Immunology       Date:  2011-02-22       Impact factor: 7.397

3.  Novel TLR7 agonist stimulates activity of CIK/NK immunological effector cells to enhance antitumor cytotoxicity.

Authors:  Dong Gao; Yongguang Cai; Yanyuan Chen; Wang Li; Chih-Chang Wei; Xiaoling Luo; Yuhuan Wang
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

4.  Contrasting roles for TLR ligands in HIV-1 pathogenesis.

Authors:  Beda Brichacek; Christophe Vanpouille; Yana Kiselyeva; Angelique Biancotto; Melanie Merbah; Ivan Hirsch; Andrea Lisco; Jean Charles Grivel; Leonid Margolis
Journal:  PLoS One       Date:  2010-09-20       Impact factor: 3.240

5.  Distinct signaling pathways regulate TLR2 co-stimulatory function in human T cells.

Authors:  Nicole M Chapman; Mahmood Y Bilal; Noemi Cruz-Orcutt; Cory Knudson; Sofia Madinaveitia; Jonathan Light; Jon C D Houtman
Journal:  Cell Signal       Date:  2012-12-05       Impact factor: 4.315

6.  The combination of early and rapid type I IFN, IL-1α, and IL-1β production are essential mediators of RNA-like adjuvant driven CD4+ Th1 responses.

Authors:  Rachel F Madera; Jennifer P Wang; Daniel H Libraty
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

Review 7.  Epithelial cell coculture models for studying infectious diseases: benefits and limitations.

Authors:  Benjamin L Duell; Allan W Cripps; Mark A Schembri; Glen C Ulett
Journal:  J Biomed Biotechnol       Date:  2011-10-05

8.  Comparative genomic analysis of buffalo (Bubalus bubalis) NOD1 and NOD2 receptors and their functional role in in-vitro cellular immune response.

Authors:  Biswajit Brahma; Sushil Kumar; Bidhan Chandra De; Purusottam Mishra; Mahesh Chandra Patra; Deepak Gaur; Meenu Chopra; Devika Gautam; Sourav Mahanty; Hrudananda Malik; Dhruba Malakar; Tirtha Kumar Datta; Sachinandan De
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

9.  Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes.

Authors:  Ruben Serrano; Daniela Wesch; Dieter Kabelitz
Journal:  Cells       Date:  2020-03-13       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.